1992
DOI: 10.1177/000331979204300106
|View full text |Cite
|
Sign up to set email alerts
|

Influence of Deproteinized Hemodialysate on Rest Pain and Walking Distance in the Presence of Peripheral Chronic Arterial Occlusive Disease

Abstract: In a controlled and randomized single-blind study (blind observer) the clinical efficacy of intra-arterial therapy with a metabolically active deproteinized dialysate from calf blood has been tested against a vasodilating and hemorheologically active reference substance (bencyclan). Over a period of four weeks 28 patients each received 20 intra-arterial infusions of the deproteinized hemodialysate 20% for infusion. The reference group with 30 patients was treated with 250 mg bencyclan in 250 mL saline 0.9%. As… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2019
2019
2019
2019

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 8 publications
0
0
0
Order By: Relevance